AJ Vaccines A/S: Financial statements 2022
CVR: 37911143
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
AJ Vaccines A/S (CVR 37911143) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 420,982,000 and a net result of DKK -268,090,000 compared with DKK -486,388,000 the year before. That is an increase of 19.6% compared with the year before. The profit margin was -63.7%. Equity in the 2022 report amounted to DKK 994,663,000. The solvency ratio was 64.8%. The company had 556 employees in the financial year.
- Revenue
- DKK 420,982,000
- Gross Profit
- DKK -65,971,000
- Profit/Loss
- DKK -268,090,000
- Equity
- DKK 994,663,000
- Total Assets
- DKK 1,534,005,000
- Employees
- 556
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 421M | -66M | -268.1M | 994.7M | 556 |
| 2021 | 351.9M | -304M | -486.4M | 815.9M | 558 |
| 2020 | 351.6M | -313.9M | -450.2M | 1.1B | 702 |
| 2019 | 323.5M | -224.5M | -288.6M | 1.2B | 719 |
| 2018 | 362.2M | -150.7M | -244.5M | 903.2M | 0 |
Official annual report
Keep an eye on AJ Vaccines A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
AJ Vaccines A/S has published its annual report for 2021. Revenue came to DKK 351,862,000, and the net result was DKK -486,388,000.
As of February 1, 2022, Shan-E-Abbas Ashary has joined the board of directors of AJ Vaccines A/S.
As of February 1, 2022, Abdulaziz Hamad Aljomaih has joined the board of directors of AJ Vaccines A/S.
As of February 1, 2022, Ole Vahlgren is registered as adm. dir. of AJ Vaccines A/S.
As of February 1, 2022, Jerome Christian Roger Cabannes has stepped down as director of AJ Vaccines A/S.
As of January 31, 2022, Tabassum Khan has left the board of directors of AJ Vaccines A/S.
As of January 31, 2022, Abdulaziz Hamad Aljomaih has left the board of directors of AJ Vaccines A/S.
As of January 31, 2022, Jesper Helmuth Larsen has stepped down as adm. dir. of AJ Vaccines A/S.
About AJ Vaccines A/S
AJ Vaccines A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Aktieselskabet af august 2016. The management consists of Ole Vahlgren. The board consists of Abdulaziz Abdulhamid Abdulrhman Albassam (chair), Mohammed Ali A Alesayi, Mustafa Nasir Farooki and Saddam Abdulqawi Hussein Alhumaikani. The company is owned by AJ Vaccines Holding ApS. The company has 499 employees (2026). In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. Equity in the 2025 report amounted to DKK 288,465,000.
